LENVITIB 4MG CAPSULES

LENVITIB 4MG CAPSULES About

LENVITIB 4 mg Capsules contain Lenvatinib, an oral anti-cancer medication classified as a multikinase inhibitor. It is widely used in the treatment of various advanced and metastatic cancers by inhibiting tumor angiogenesis and cancer cell proliferation.

• Active Ingredient: Lenvatinib

• Strength: 4 mg

• Dosage Form: Capsule

• Packaging Type: Strip / Bottle (as per availability)

• Advanced thyroid cancer (radioiodine-refractory)

• Hepatocellular carcinoma (HCC)

• Renal cell carcinoma (in combination therapy)

• Other solid tumors as prescribed by an oncologist

Lenvatinib works by blocking multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and cancer progression, thereby slowing or stopping cancer cell development.

• To be taken orally as directed by the physician

• Dosage depends on patient condition and treatment protocol

• Do not crush or open the capsule

• Effective targeted therapy for multiple cancers

• Oral administration for patient convenience

• Helps reduce tumor blood supply

• Proven efficacy in advanced-stage cancers

• Store below 25C

• Protect from light and moisture

• Keep out of reach of children

• Prescription medicine; use only under medical supervision

• Not recommended during pregnancy or breastfeeding

• Monitor blood pressure and liver function regularly

 4 mg Capsules contain Lenvatinib, an oral anti-cancer medication classified as a multikinase inhibitor. It is widely used in the treatment of various advanced and metastatic cancers by inhibiting tumor angiogenesis and cancer cell proliferation.

• Active Ingredient: Lenvatinib

• Strength: 4 mg

• Dosage Form: Capsule

• Packaging Type: Strip / Bottle (as per availability)

• Advanced thyroid cancer (radioiodine-refractory)

• Hepatocellular carcinoma (HCC)

• Renal cell carcinoma (in combination therapy)

• Other solid tumors as prescribed by an oncologist

Lenvatinib works by blocking multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and cancer progression, thereby slowing or stopping cancer cell development.

• To be taken orally as directed by the physician

• Dosage depends on patient condition and treatment protocol

• Do not crush or open the capsule

• Effective targeted therapy for multiple cancers

• Oral administration for patient convenience

• Helps reduce tumor blood supply

• Proven efficacy in advanced-stage cancers

• Store below 25C

• Protect from light and moisture

• Keep out of reach of children

• Prescription medicine; use only under medical supervision

• Not recommended during pregnancy or breastfeeding

• Monitor blood pressure and liver function regularly